Anna Berkenblit

Phase III study to evaluate temsirolimus compared with investigator's choice therapy for the treatment of relapsed or refractory mantle cell lymphoma

Journal of Clinical Oncology · 2009 · 522 citations

Mirvetuximab Soravtansine in FRα-Positive, Platinum-Resistant Ovarian Cancer

New England Journal of Medicine · 2023 · 405 citations